SCHEMBL1978647

SCHEMBL1978647

CCCCCCCCCCC[CH]CC(O)CO

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.46
DGKA P23743 1/20 0.45
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
SPHK2 Q9NRA0 4/20 0.44
SPHK1 Q9NYA1 4/20 0.44
LMNA P02545 4/20 0.44
MAPT P10636 3/20 0.44
CETP P11597 3/20 0.44
GMNN O75496 2/20 0.44
GLA P06280 2/20 0.44
POLB P06746 2/20 0.44
THRB P10828 2/20 0.44
MAPK1 P28482 2/20 0.44
CXCR5 P32302 2/20 0.44
CCR6 P51684 2/20 0.44
BLM P54132 2/20 0.44
UBE2N P61088 2/20 0.44
CYP2D6 P10635 2/20 0.44
ALDH1A1 P00352 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18763294 1.00 USP2 (0.46) USP2DGKAMEN1KMT2ASPHK2
SCHEMBL8106179 1.00 USP2 (0.46) USP2DGKAMEN1KMT2ASPHK2
SCHEMBL11410792 1.00 USP2 (0.46) USP2DGKAMEN1KMT2ASPHK2
SCHEMBL9568707 0.94 DGKA (0.53) DGKAMEN1KMT2ASPHK2SPHK1
SCHEMBL5134831 0.91 USP2 (0.39) USP2DGKAMEN1KMT2ASPHK2
SCHEMBL8905090 0.83 FFAR1 (0.54) SPHK1LMNAFAAHFFAR1FFAR4
SCHEMBL9321967 0.82
SCHEMBL10597750 0.82 FFAR1 (0.57) DGKAMEN1KMT2ASPHK2SPHK1
SCHEMBL28807135 0.82 FFAR1 (0.38) DGKAMEN1KMT2ASPHK2SPHK1
SCHEMBL28458718 0.82 FFAR1 (0.57) DGKAMEN1KMT2ASPHK2SPHK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-60110742-A None JP disclosed
US-11311474-B2 Transparent personal cleansing compositions GALAXY SURFACTANTS LTD. (IN) 2022-04-26 US disclosed
US-20200289401-A1 TRANSPARENT PERSONAL CLEANSING COMPOSITIONS GALAXY SURFACTANTS LTD. (IN) 2020-09-17 US disclosed
US-20150210596-A1 CHOPPED STRAND FOR CEMENT STRUCTURE, AND CEMENT STRUCTURE NIPPON ELECTRIC GLASS CO., LTD. (JP) 2015-07-30 US disclosed
EP-2335681-A1 Cleansing composition KPSS-Kao Professional Salon Services GmbH (DE) 2011-06-22 EP disclosed
US-20080089854-A1 Skin care compositions WHEWELL CHRISTOPHER J 2008-04-17 US disclosed
US-4812254-A NONIRRITATING TO SKIN AND HAIR, SOAPS, SHAMPOO, PHOSPHATES KAO CORPORATION (JP) 1989-03-14 US disclosed
JP-S60110742-A VINYL CHLORIDE RESIN COMPOSITION FOR STRETCHED FILM DENKI KAGAKU KOGYO KK 1985-06-17 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200289401-A1 TRANSPARENT PERSONAL CLEANSING COMPOSITIONS CUTA, ELOVL3, FFAR3 USP2 1854/4885DGKA 1531/4885MEN1 4578/4885
US-20080089854-A1 Skin care compositions CUTA, MGLL, LPO USP2 1405/4885DGKA 66/4885MEN1 3663/4885
US-11311474-B2 Transparent personal cleansing compositions CUTA, ELOVL3, FFAR3 USP2 1854/4885DGKA 1531/4885MEN1 4578/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.